X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (29) 29
female (27) 27
male (26) 26
endocrinology & metabolism (21) 21
adult (19) 19
middle aged (19) 19
insulin (11) 11
insulin resistance (11) 11
obesity (11) 11
abridged index medicus (9) 9
metabolism (9) 9
aged (8) 8
analysis (8) 8
blood glucose - metabolism (8) 8
animals (7) 7
body mass index (7) 7
glucose (7) 7
diabetes (6) 6
physiological aspects (6) 6
proteins (6) 6
diet (5) 5
glucose - metabolism (5) 5
glucose tolerance test (5) 5
insulin - blood (5) 5
insulin resistance - physiology (5) 5
mice (5) 5
obesity - metabolism (5) 5
rats (5) 5
resistance (5) 5
risk (5) 5
type 2 diabetes (5) 5
dextrose (4) 4
dietary fiber - administration & dosage (4) 4
disease (4) 4
double-blind method (4) 4
expression (4) 4
homeostasis (4) 4
hormone (4) 4
inflammation (4) 4
insulin sensitivity (4) 4
lipids (4) 4
liver - metabolism (4) 4
medicine (4) 4
nutrition (4) 4
reference values (4) 4
research article (4) 4
testosterone (4) 4
adipocytes (3) 3
adipose tissue - metabolism (3) 3
adipose-tissue (3) 3
biomarkers (3) 3
cardiac & cardiovascular systems (3) 3
cross-over studies (3) 3
diabetes mellitus (3) 3
diabetes mellitus type 2 (3) 3
diabetes mellitus, type 1 - drug therapy (3) 3
dose-response relationship, drug (3) 3
endocrinology (3) 3
factor-i (3) 3
fibroblast growth factors - blood (3) 3
glucagon (3) 3
glucagon - pharmacology (3) 3
glucose clamp technique (3) 3
glucose metabolism (3) 3
health aspects (3) 3
hormones (3) 3
hormones, hormone substitutes, and hormone antagonists (3) 3
insulin - metabolism (3) 3
insulin-like growth factor i - metabolism (3) 3
internal medicine (3) 3
kinases (3) 3
lipid metabolism (3) 3
liver (3) 3
medicine & public health (3) 3
metabolic diseases (3) 3
metabolic syndrome (3) 3
nutrition & dietetics (3) 3
obesity - blood (3) 3
obesity - physiopathology (3) 3
overweight (3) 3
prevalence (3) 3
prospective studies (3) 3
research (3) 3
rodents (3) 3
science (3) 3
secretion (3) 3
sensitivity (3) 3
serum (3) 3
sex factors (3) 3
acromegaly - drug therapy (2) 2
adolescent (2) 2
age factors (2) 2
aging - blood (2) 2
aldosterone (2) 2
aldosterone-producing adenoma (2) 2
article (2) 2
atrial natriuretic factor - blood (2) 2
biology (2) 2
biomarkers - blood (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oxidative Medicine and Cellular Longevity, ISSN 1942-0900, 2017, Volume 2017, pp. 3035184 - 13
Insulin-like growth factor binding protein-2 (IGFBP-2) is the predominant IGF binding protein produced during adipogenesis and is known to increase the... 
MOUSE SKELETAL-MUSCLE | TRANSPORT | OBESITY | IGFBP-2 | HORMONE | DIFFERENTIATION | FACTOR-I RECEPTOR | EXPRESSION | ADIPOSE-TISSUE | STIMULATED PHOSPHORYLATION | CELL BIOLOGY | Proteins | Nutrition | Rodents | Insulin-like growth factors | Glucose | Adipocytes | Kinases
Journal Article
Materials, ISSN 1996-1944, 03/2016, Volume 9, Issue 3, pp. 162 - 162
Journal Article
Diabetes, ISSN 0012-1797, 05/2013, Volume 62, Issue 5, pp. 1453 - 1463
Glucagon, an essential regulator of glucose homeostasis, also modulates lipid metabolism and promotes weight loss, as reflected by the wasting observed in... 
PPAR-ALPHA | BODY-WEIGHT | METABOLISM | FIBROBLAST-GROWTH-FACTOR-21 | PHARMACOLOGY | INCREASES ENERGY-EXPENDITURE | ENDOCRINOLOGY & METABOLISM | DEGRADATION | MICE | INSULIN SENSITIVITY | FGF21 | Obesity - drug therapy | Humans | Peptides - pharmacokinetics | Fibroblast Growth Factors - genetics | Male | Fibroblast Growth Factors - secretion | Obesity - blood | Anti-Obesity Agents - therapeutic use | Glucagon - agonists | Fibroblast Growth Factors - metabolism | Anti-Obesity Agents - pharmacokinetics | Peptides - chemical synthesis | Hepatocytes - secretion | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Hypoglycemic Agents - pharmacokinetics | Peptides - physiology | Rats | Hypoglycemic Agents - pharmacology | Mice, Knockout | Cross-Over Studies | Anti-Obesity Agents - chemical synthesis | Mice | Anti-Obesity Agents - pharmacology | Hepatocytes - pathology | Diabetes Mellitus, Type 2 - metabolism | Hepatocytes - metabolism | Molecular Targeted Therapy | Mice, Mutant Strains | HEK293 Cells | Adult | Female | Hepatocytes - drug effects | Recombinant Proteins - metabolism | Double-Blind Method | Cells, Cultured | Insulin Resistance | Receptors, Glucagon - metabolism | Recombinant Proteins - agonists | Glucagon - pharmacology | Obesity - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Fibroblast Growth Factors - blood | Hypoglycemic Agents - chemical synthesis | Glucagon - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptides - therapeutic use | Physiological aspects | Fibroblast growth factors | Research | Glucagon | Analysis | Original Research
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 09/2017, Volume 102, Issue 9, pp. 3480 - 3490
CONTEXT:Depending on its lipolytic activity, glucagon plays a promising role in obesity treatment. Glucagon-induced growth hormone (GH) release can promote its... 
FOXO | STIMULATION | GROWTH-HORMONE | GHRELIN | ENDOCRINOLOGY & METABOLISM | SECRETION | SUPPRESSION | EXPRESSION | AXIS | Humans | Insulin-Like Growth Factor Binding Proteins - drug effects | Diabetes Mellitus, Type 1 - metabolism | Glucagon - administration & dosage | Male | Insulin-Like Growth Factor I - drug effects | Forkhead Box Protein O1 - drug effects | Dose-Response Relationship, Drug | Statistics, Nonparametric | Adult | Female | Forkhead Box Protein O1 - metabolism | Double-Blind Method | Drug Administration Schedule | Enzyme-Linked Immunosorbent Assay | Growth Hormone - drug effects | Growth Hormone - metabolism | Obesity - physiopathology | Injections, Intramuscular | Blotting, Western | Diabetes Mellitus, Type 1 - drug therapy | Obesity - metabolism | Insulin-Like Growth Factor Binding Proteins - metabolism | Diabetes Mellitus, Type 1 - diagnosis | Insulin-Like Growth Factor I - metabolism | TOR protein | Phosphorylation | Glucagon | Insulin-like growth factor I | Insulin-like growth factor-binding protein 2 | Insulin-like growth factor-binding protein 1 | AKT protein | Insulin-like growth factors | Kinases | Proteins | Biomedical materials | Reduction | FOXO1 protein | Osteosarcoma | Forkhead protein | Insulin-like growth factor-binding protein 3 | Biocompatibility | Lipid metabolism | Protein transport | Translocation | Obesity | Secretion | Diabetes mellitus | Rapamycin | Osteosarcoma cells | Gene expression | Metabolism | Insulin | Biological activity | Nuclear transport | Hepatocytes | Growth hormone
Journal Article
Diabetologia, ISSN 0012-186X, 6/2018, Volume 61, Issue 6, pp. 1295 - 1305
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2010, Volume 35, Issue 3, pp. 382 - 391
Journal Article